Contact Us

+350 20079000 info@hassans.gi

This data will only be used by Hassans for processing your query and for no other purpose. View our privacy policy

Time to pay attention to Psychedelic Medicine says The Motley Fool

As previously highlighted in other posts, investors should keep an eye out for stocks in the psychedelic medicine space. Mind Medecine, Compass Pathways and Field Trip Ventures are all candidates to go public in the next 12 months. 

Are we with psychedelic medicine where we were with cannabis 10-15 years ago?

What's important to understand is that a paradigm shift is starting to taking shape within the Western medical community. In effect, scientists are increasingly intrigued by the therapeutic potential of psychedelics as treatments for a whole range of mental health disorders. Pyschedelic medicine thus has the potential to be a gold mine for early investors. www.fool.com/...

Hassans advises on Gibraltar’s first ever competition law claim.

Gibfibre Limited’s multimillion pound competition law claim against Gibtelecom & Rockolo is dismissed in its entirety. Today, the Supreme...

Posted on
Read more

Latest Insights

Once bitten, twice awry

In the context of international sporting events, the Gibraltar issue appears to be ensnaring all those who venture a misplaced and ill...

Posted on
Read more

Group Personal Pension Schemes

Are you a private sector employer? Have you considered the benefits of Group Personal Pension Schemes? Following the introduction of the...

Posted on
Read more

Hassans advises on Gibraltar’s first ever competition law claim.

Gibfibre Limited’s multimillion pound competition law claim against Gibtelecom & Rockolo is dismissed in its entirety. Today, the Supreme...

Posted on
Read more